Abstract
Infectious diseases is the only area of medicine where we can isolate the cause and study it in the laboratory under conditions similar to human body. Once isolated, we are able to determine the most optimal drug to treat it. Unfortunately, it is also the only specialty where after making truly wondrous strides we find ourselves at the crossroads of a public health crisis in the form of ongoing antibiotic resistance. Among the factors responsible for the current status, is the suboptimal utilization of the diagnostic microbiology laboratory. In this review authors provide a short historical perspective of diagnostic microbiology. The focus of discussion is the generation and utilization of cumulative antibiograms at the institutional and regional levels and discuss the pitfalls in large national databases with respect to the day-to-day patient care. This public health tool to slow down antibiotic resistance happens to be low-tech and inexpensive.
Similar content being viewed by others
References
Caliendo AM, Gilbert DN, Ginocchio CC, et al; Infectious Diseases Society of America (IDSA). Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57:S739–70.
Khardori N. Future of diagnostic microbiology. Indian J Med Microbiol. 2014;32:371–7.
Wheat PF. History and development of antimicrobial susceptibility testing methodology. J Antimicrob Chemother. 2001;48:1–4.
National Committee for Clinical Laboratory Standard (1975). Performance standards for antimicrobial disk susceptibility tests approved standard. M2 – A7 ASM-2, NCCLS, Villanova, PA.
Courvalin P. Genotypic approach to the study of bacterial resistance to antibiotics. Antimicrob Agents Chemother. 1991;35:1019–23.
Tenover FC. Bauer and Kirby meet Watson and Crick: antimicrobial susceptibility testing in the molecular era. ASM News. 1992;5:669–72.
Bergeron MG, Ouellette M. Preventing antibiotic resistance through rapid genotype identification of bacterial and of their antibiotic resistance genes in the clinical microbiology laboratory. J Clin Microbiol. 1998;36:2169–72.
El-Azizi M, Mushtaq A, Drake C, et al. Evaluating antibiogram to monitor drug resistance. Emerg Infect Dis. 2005;11:1301–2.
Var SK, Hadi R, Khardori NM. Evaluation of regional antibiograms to monitor antimicrobial resistance in Hampton Roads, Virginia. Ann Clin Microbiol Antimicrob. 2015;14:22.
Silvaggio J, Terashita D, Marquez P, Flood A, Mende ZJ, McKinell JA. Development of a regional antibiogram to monitor burden and distribution of multi-drug resistant organisms across the spectrum of care in Los Angeles County. Open Forum Infect Dis. 2016;3:329.
Humphries R, Mendez J, Miller LG, et al. The regional antibiogram is an important public health tool to improve empire antibiotic selection, Senotrophomonas maltophilia as a case example. Open Forum Infect Dis. 2017;4:S258.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sundareshan, V., Khardori, N. Diagnostic Microbiology from the Beginning to the Future: Regional Antibiograms as Public Health Tools to Slow Down Antibiotic Resistance. Indian J Pediatr 87, 48–50 (2020). https://doi.org/10.1007/s12098-019-03124-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-019-03124-x